Treatment Delivery
Nine patients (eight NAC, one control) withdrew immediately after random assignment, providing no trial-specific follow-up. Of 691 allocated to NAC who provided clinical follow-up (Fig CONSORT diagram showing flow of patients through the FOxTROT trial. FOxTROT, Fluorouracil, Oxaliplatin, and Targeted Receptor preoperative therapy.